UA64074C2 - Cardioprotective antioxidant drug "elgacin" - Google Patents

Cardioprotective antioxidant drug "elgacin"

Info

Publication number
UA64074C2
UA64074C2 UA2002086603A UA200286603A UA64074C2 UA 64074 C2 UA64074 C2 UA 64074C2 UA 2002086603 A UA2002086603 A UA 2002086603A UA 200286603 A UA200286603 A UA 200286603A UA 64074 C2 UA64074 C2 UA 64074C2
Authority
UA
Ukraine
Prior art keywords
cardioprotective
elgacin
antioxidant drug
complex
antioxidant
Prior art date
Application number
UA2002086603A
Other languages
Russian (ru)
Ukrainian (uk)
Other versions
UA64074A (en
Inventor
Тамара Нігматовна Бікбулатова
Анатолій Севастянович Шаламай
Людмила Василівна Безпалько
Євген Олександрович Сова
Валентин Петрович Черних
Лариса Василівна Яковлєва
Ольга Павлівна Хворост
Тетяна Семенівна Сахарова
Світлана Анатолієвна Малиновська
Євген Володимирович Гладух
Олександр Костянтинович Івахненко
Original Assignee
Закрите Акціонерне Товариство Науково-Виробничий Центр "Борщагівський Хіміко-Фармацевтичний Завод"
Національна Фармацевтична Академія України
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Закрите Акціонерне Товариство Науково-Виробничий Центр "Борщагівський Хіміко-Фармацевтичний Завод", Національна Фармацевтична Академія України filed Critical Закрите Акціонерне Товариство Науково-Виробничий Центр "Борщагівський Хіміко-Фармацевтичний Завод"
Priority to UA2002086603A priority Critical patent/UA64074C2/en
Publication of UA64074A publication Critical patent/UA64074A/en
Publication of UA64074C2 publication Critical patent/UA64074C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fats And Perfumes (AREA)

Abstract

The invention relates to the cardioprotective antioxidant drug containing the complex of ellagotannins as the active ingredient. The complex extracted from the infructescences of the alder comprises ellagic acid, dilactone of the valonic acid, and the products of their interaction.
UA2002086603A 2002-08-08 2002-08-08 Cardioprotective antioxidant drug "elgacin" UA64074C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UA2002086603A UA64074C2 (en) 2002-08-08 2002-08-08 Cardioprotective antioxidant drug "elgacin"

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UA2002086603A UA64074C2 (en) 2002-08-08 2002-08-08 Cardioprotective antioxidant drug "elgacin"

Publications (2)

Publication Number Publication Date
UA64074A UA64074A (en) 2004-02-16
UA64074C2 true UA64074C2 (en) 2005-06-15

Family

ID=82839708

Family Applications (1)

Application Number Title Priority Date Filing Date
UA2002086603A UA64074C2 (en) 2002-08-08 2002-08-08 Cardioprotective antioxidant drug "elgacin"

Country Status (1)

Country Link
UA (1) UA64074C2 (en)

Also Published As

Publication number Publication date
UA64074A (en) 2004-02-16

Similar Documents

Publication Publication Date Title
MY140840A (en) Acylated, heteroaryl-condensed cycloalkenylamines and their use as pharmaceuticals
IL162214A (en) Pyridine derivatives and pharmaceutical compositions containing the same
SE0001899D0 (en) New compounds
MXPA04004837A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1.
IL161154A0 (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
GB0222495D0 (en) Compounds
MY119231A (en) Novel lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
EP1725536B8 (en) Imidazoline derivatives having cb1-antagonistic activity
TW200612903A (en) Use of trisubstituted benzopyranones
SI1730144T1 (en) Substituted 1,4,8-triazaspiro 4.5 decan-2-one compounds
IL160171A0 (en) Depsipeptide derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
RS44204A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
WO2004091591A3 (en) Nutritional or therapeutic composition containing the compound oleuropeine or one of the derivatives thereof
HK1090354A1 (en) Novel dibenzo [b,f]oxepine-10-carboxamides and pharmaceutical uses thereof
EP1736470A3 (en) Pyrimidine derivatives as CB2 cannabinoid receptor modulators
WO2004039326A3 (en) Propofol with cysteine
MXPA05012679A (en) Novel imidazole derivatives, the production thereof, and the use of the same as a medicament.
MXPA04005552A (en) Vitamin d analogues.
PL346143A1 (en) Tan-1057 derivatives
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
TW200503785A (en) Dosage form containing (S)-pantoprazole as active ingredient
RS44304A (en) Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
MY133230A (en) Combination of no synthase inhibitor(s) and metabolic antioxidant(s)
EA200600998A1 (en) PHARMACEUTICAL COMPOSITION CONTAINING A ZINC-HYALURONANE COMPLEX, INTENDED FOR THE TREATMENT OF SCATTERED SCLEROSIS
UA64074C2 (en) Cardioprotective antioxidant drug "elgacin"